India

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 1. Investing in Health
   1. Child Health
   2. Health System Development and Finance
   3. The 20th Century Takeoff in Human Health
2. 2. Intervention Cost–Effectiveness: Overview of Main Messages
   1. Assessing the Evidence on the Cost-Effectiveness of Interventions
3. 4. Priorities for Global Research and Development of Interventions
   1. Key Recommendations
   2. Needs, Context, Opportunities, and Major Challenges
4. 5. Science and Technology for Disease Control: Past, Present, and Future
   1. Medicine before the 20th Century
   2. Science, Technology, and Medicine in the 20th Century
   3. Science, Technology, and Medicine in the Future
5. 6. Product Development Priorities
   1. Financing and Institutional Arrangements for New Product Development
   2. Intellectual Property
   3. Introduction
6. 7. Economic Approaches to Valuing Global Health Research
   1. The Value of Health Research
7. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
   1. What Do Countries Need To Do?
8. 10. Gender Differentials in Health
   1. Antecedents
9. 11. Fiscal Policies for Health Promotion and Disease Prevention
10. 13. Recent Trends and Innovations in Development Assistance for Health
    1. Recent Innovations to Improve the Effectiveness of Development Assistance for Health
11. 15. Cost–Effectiveness Analysis for Priority Setting
    1. Determining Costs for Interventions
12. 16. Tuberculosis
    1. Alternative and Complementary Approaches to the Diagnosis and Treatment of Active Disease
    2. Conclusions
    3. Cost-Effectiveness of Interventions against Tuberculosis
    4. Epidemiological Burden and Trends
    5. Summary of Cost-Effectiveness Analyses
13. 17. Sexually Transmitted Infections
    1. Bacterial and Viral STIs and Their Sequelae
14. 18. HIV/AIDS Prevention and Treatment
    1. Action under Uncertainty
    2. Care and Treatment
15. 19. Diarrheal Diseases
    1. Case Management
    2. Preventive Strategies
    3. Syndromic Diagnosis
16. 20. Vaccine–Preventable Diseases
    1. Cost-Effectiveness of Increasing Immunization Coverage for the Traditional EPI
    2. Costs and Cost-Effectiveness of Adding New Antigens to the Current Immunization Schedule
17. 21. Conquering Malaria
    1. Causes, Epidemiology, Manifestations, and Diagnosis
18. 22. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy
    1. Conclusion
    2. Costs and Cost-Effectiveness of Interventions
    3. Disease Burden
    4. Interventions and Their Effectiveness
19. 23. Tropical Diseases Lacking Adequate Control Measures: Dengue, Leishmaniasis, and African Trypanosomiasis
    1. Costs and Cost-Effectiveness of Interventions
    2. Disease Characteristics and Transmission
    3. Management and Control Strategies
    4. Problems and Challenges for Disease Control
20. 24. Helminth Infections: Soil–Transmitted Helminth Infections and Schistosomiasis
21. 25. Acute Respiratory Infections in Children
    1. Interventions
22. 27. Newborn Survival
    1. Implementation
    2. Interventions
    3. Marginal Impact and Cost of Scaling Up Universal Neonatal Packages
    4. Neonatal Deaths
23. 28. Stunting, Wasting, and Micronutrient Deficiency Disorders
    1. Interventions
24. 29. Health Service Interventions for Cancer Control in Developing Countries
    1. Conclusions
    2. Cost-Effectiveness of Cancer Control Interventions
25. 30. Diabetes: The Pandemic and Potential Solutions
    1. Cost-Effectiveness of Interventions and Priorities
    2. Lessons and Experience
26. 31. Mental Disorders
27. 32. Neurological Disorders
    1. AD and Other Dementias
    2. Cost-Effectiveness of Interventions in Developing Countries
    3. Epilepsy
    4. Parkinson's Disease
    5. Recommendations
    6. Stroke
28. 33. Cardiovascular Disease
    1. Burden of Disease
    2. Conclusions: Pitfalls and Promises
    3. Research and Development
29. 34. Inherited Disorders of Hemoglobin
    1. Burden of Disease
    2. Control and Treatment
    3. Introduction
30. 35. Respiratory Diseases of Adults
    1. Chronic Respiratory Diseases: Nature, Causes, and Burden
31. 36. Diseases of the Kidney and the Urinary System
    1. Causes of Diseases of the Kidney and Urinary System
    2. Economic Benefits of Intervention
    3. Global Perspectives in Relation to RRT
    4. Implementation of Control Strategies: Lessons of Experience
32. 37. Skin Diseases
    1. Skin Diseases
33. 38. Oral and Craniofacial Diseases and Disorders
    1. Aspects of Treatment of Cavities and of Caries Disease
    2. Oral Manifestations of HIV/AIDS
34. 39. Unintentional Injuries
    1. Burden and Causes of Unintentional Injuries
35. 41. Water Supply, Sanitation, and Hygiene Promotion
    1. Water Supply
36. 42. Indoor Air Pollution
    1. Implementation of Control Strategies: Lessons from Experience
    2. Intervention Costs and Effectiveness
    3. Nature, Causes, and Burden of Condition
37. 43. Air and Water Pollution: Burden and Strategies for Control
    1. Economic Benefits of Interventions
    2. Implementation of Control Strategies: Lessons of Experience
    3. Nature, Causes, and Burden of Air and Water Pollution
38. 44. Prevention of Chronic Disease by Means of Diet and Lifestyle Changes
    1. Cost-Effectiveness of Interventions
    2. Interventions
39. 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight
    1. Burden of the Disease, Condition, or Risk Factor
    2. Cost-Effectiveness of Interventions
40. 46. Tobacco Addiction
    1. Health Consequences of Smoking
    2. Smoking Trends
41. 48. Illicit Opiate Abuse
    1. Nature, Causes, and Health Consequences of Illicit Opioid Use
42. 50. Loss of Vision and Hearing
43. 51. Cost–Effectiveness of Interventions for Musculoskeletal Conditions
    1. Nature, Causes, and Epidemiology of Musculoskeletal Conditions
    2. Treatments
44. 52. Pain Control for People with Cancer and AIDS
    1. Costs and Cost-Effectiveness
    2. Implementation of Strategies to Improve Pain Control
45. 53. Public Health Surveillance: A Tool for Targeting and Monitoring Intervention
    1. Surveillance as a Tool to Improve Public Health
    2. Surveillance for Specific Conditions
46. 54. Information to Improve Decision Making for Health
    1. Systems and Supply of Health Information
47. 55. Drug Resistance
    1. Implementation of Strategies: Two Lessons from Experience
    2. Risk Factors
48. 56. Community Health and Nutrition Programs
    1. Community-Based Programs—What Are They?
    2. Contextual Factors
    3. Future Applications
    4. Programmatic Factors
    5. Research Needs
    6. Results
    7. What Is Known about Efficacy and Effectiveness
49. 57. Contraception
    1. Interventions
    2. Organization of Family-Planning Programs
50. 58. School–Based Health and Nutrition Programs
    1. Economic Benefits of Intervention
51. 59. Adolescent Health Programs
    1. Costs and Cost-Effectiveness of Interventions
52. 60. Occupational Health
    1. Economic Aspects of Intervention
53. 61. Natural Disaster Mitigation and Relief
    1. Disasters as a Public Health Condition
54. 62. Control and Eradication
    1. Disease-Specific Case Studies
55. 65. The District Hospital
    1. Economics of District Hospitals: A Summary of Reported Experience
56. 66. Referral Hospitals
57. 67. Surgery
    1. Costs and Cost-Effectiveness of Interventions
58. 68. Emergency Medical Services
    1. Interventions for Emergency Care: Systems, Structures, and Organization
59. 69. Complementary and Alternative Medicine
    1. Definitions and Domains of Complementary and Alternative Medicine and Traditional Medicine
    2. Demography, Use, Toxicity, and Efficacy
60. 70. Improving the Quality of Care in Developing Countries
    1. Policy Interventions to Improve Quality
    2. Quality of Care in Developing Countries
61. 71. Health Workers: Building and Motivating the Workforce
    1. Health Worker Incentives
62. 72. Ensuring Supplies of Appropriate Drugs and Vaccines
    1. Issues for the Future
    2. Selection of Drugs

Global Burden of Disease and Risk Factors

1. 1. Measuring the Global Burden of Disease and Risk Factors, 1990—2001
2. 2. Demographic and Epidemiological Characteristics of Major Regions, 1990—2001
   1. Changes in Mortality, 1990–2001
   2. Discussion
3. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
   1. Acknowledgments
   2. Discussion and Conclusions
   3. Estimating Deaths by Cause: Methods and Data
   4. Global and Regional Mortality in 2001

Priorities in Health

1. 1. Accomplishments, Challenges, and Priorities
   1. Accounting for Health Gains
   2. An Agenda for Action
   3. Equity
2. 2. Success in Addressing Priorities
   1. Successes Despite Weak Health Systems
3. 3. Cost–Effectiveness Analysis
   1. How Can Policy Makers Use Cost-Effectiveness Analysis?
4. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
   1. Maternal and Neonatal Health
5. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
   1. Tobacco Use
6. 6. Providing Interventions
   1. Cross-Level Services and Inputs
   2. Levels of Care

Chapter Presentations

Chapter 01. Investing in Health

1. Rate of Change in Life Expectancy, 1960-2002, By World Bank Region

Chapter 27. Newborn Survival

1. Cost of Adding Newborn Care Packages to Maternal and Child Health Services

Chapter 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight

1. Estimates of Cost-effectiveness of a Polypill for Cardiovascular Disease in India